search
Back to results

The Effect of a Self-Retaining Pannus Retractor in Obese Patients Undergoing Cesarean Section (Traxi)

Primary Purpose

Obese Patients Undergoing Cesarean Section

Status
Terminated
Phase
Not Applicable
Locations
Study Type
Interventional
Intervention
Traxi Pannus Retractor
Sponsored by
St. Louis University
About
Eligibility
Locations
Arms
Outcomes
Full info

About this trial

This is an interventional supportive care trial for Obese Patients Undergoing Cesarean Section

Eligibility Criteria

14 Years - 50 Years (Child, Adult)FemaleDoes not accept healthy volunteers

Inclusion Criteria:

  • Pregnant women with a BMI greater than or equal to 30 kg/m squared, aged 14-50 years old, undergoing non-emergent cesarean section for delivery and require pannus displacement for surgery.

Physicians Inclusion would include any physician who routinely perform C-sections

Exclusion Criteria:

  • Patients undergoing emergency Cesarean-section Pre-existing concurrent infection including chorioamnionitis State of immunosuppression (ie. HIV, cancer) Long-term steroid use (>2 days) Patients with a BMI <30 kg/m2, or those with a BMI >/=30kg who do not require pannus retraction.

If there is a rash in the area of retraction Adhesive/tape allergy. Physicians exclusion would include any physician who does not routinely perform C-sections.

Sites / Locations

    Arms of the Study

    Arm 1

    Arm 2

    Arm Type

    Active Comparator

    No Intervention

    Arm Label

    Treatment

    Standard

    Arm Description

    Subjects will receive use of the Traxi pannus retractor when undergoing cesarean section

    Patients will receive use of the standard of care option which is the montgomery straps

    Outcomes

    Primary Outcome Measures

    Wound Disruption Rates
    To determine if there is a difference in wound disruption rates, in obese patients who have Cesarean sections when the Traxi retractor is used during Cesarean sections, when compared to traditional pannus retractor techniques, montogmery straps.

    Secondary Outcome Measures

    Duration of Surgery or Length of Time From Skin Incision to Delivery of the Infant
    To determine if there is a difference in duration of surgery or length of time from skin incision to delivery of the infant between the treatment group and the control/standard group.
    Change in Hemoglobin
    To determine if there is a difference in change in hemoglobin between the control/standard group and the treatment group.
    Estimated Blood Loss
    To determine if there is a difference in estimated blood loss between the treatment group and the control/standard group.
    Postoperative Length of Stay
    To determine if there is a difference in postoperative length of stay between the treatment group and the control/standard group.
    Other Complication Rate
    To determine if there is a difference in other complication rates between the treatment group and the control/standard group.
    Need for Hospital Readmission or Emergency Room Visits
    To determine if there is a difference in need for hospital readmission or emergency room visits between the treatment group and the control/standard group.

    Full Information

    First Posted
    August 4, 2016
    Last Updated
    May 2, 2018
    Sponsor
    St. Louis University
    search

    1. Study Identification

    Unique Protocol Identification Number
    NCT02865083
    Brief Title
    The Effect of a Self-Retaining Pannus Retractor in Obese Patients Undergoing Cesarean Section
    Acronym
    Traxi
    Official Title
    The Effect of a Self-Retaining Pannus Retractor in Obese Patients Undergoing Cesarean Section
    Study Type
    Interventional

    2. Study Status

    Record Verification Date
    May 2018
    Overall Recruitment Status
    Terminated
    Why Stopped
    unable to reach enrollment goal
    Study Start Date
    June 1, 2016 (Actual)
    Primary Completion Date
    January 2, 2017 (Actual)
    Study Completion Date
    January 2, 2017 (Actual)

    3. Sponsor/Collaborators

    Responsible Party, by Official Title
    Principal Investigator
    Name of the Sponsor
    St. Louis University

    4. Oversight

    Data Monitoring Committee
    No

    5. Study Description

    Brief Summary
    The purpose of this study is to investigate the effects of the Traxi Pannus retractor in obese patients (BMI ≥30 kg/m2) who undergo Cesarean sections compared to routine pannus retraction techniques. Patients will be randomized to the use of the Traxi retractor during Cesarean section (treatment group) or the use of traditional pannus retraction techniques (control group). The primary outcome to be followed is surgical site disruption. The investigators will also assess the duration of surgery or length of time from skin incision to delivery of the infant, change in hemoglobin, estimated blood loss, postoperative length of stay, need for hospital readmission or emergency room visits, or other complication rates between the two groups.
    Detailed Description
    Surgical site infections (SSI) are an important cause of morbidity following cesarean sections. The rate of surgical site infections following cesarean section in the United States is estimated between 3-15%, depending on the population studied, definitions of surgical site infection used, and length of time studied and is often underestimated. Morbidities include longer length of hospital stay, hospital readmission, wound opening and re-exploration, need for home health care, increased health care costs and loss of productivity. The risk of developing a SSI after a Cesarean section is increased with certain patient characteristics, such as obesity and duration of surgery and is decreased with the use prophylactic antibiotics prior to the skin incision. Obesity is a significant public health problem and the incidence continues to increase in the United States. It has been shown to be associated with increased risk of SSI after cesarean section in several studies. Olsen et al reviewed 1,605 patients who underwent cesarean section and found increased BMI at admission was an independent risk factor for SSI. In another study of 19,416 women in Israel who had cesarean deliveries, women who had a BMI ≥30 kg/m2 had an increased risk for infection (odds ratio [OR} =2.2; 95% Confidence Interval [CI]. Leth, et al. also found obesity as a risk factor associated with wound infection. In this study of 2,492 consecutive women who had cesarean sections in Denmark, infection rates increased with increasing BMI, with women with a BMI kg/m2 30.0-34.9 having an infection rate of 19.1% and women with a BMI of 35.0-39.9 kg/m2 and of ≥40 kg/m2 both having infection rates of 31.1%. Hypotheses for the increased rate of wound infections in obese patients include decreased vascularity of adipose tissue, increase in wound area, and poorer penetration of prophylactic antibiotics to adipose tissue. Adequate surgical exposure and good visualization are paramount in abdominal surgery. Retraction of the pannus cephalad is often required for adequate visualization and access to the lower abdomen and thus the lower uterine segment. Several studies have been shown that pfannensteil or joel-cohen incisions are superior to vertical incisions due to increased risk of classical cesarean delivery in the case of the obese gravida. Limited studies have been completed to assess supra umbilical incisions. Other methods of pannus retraction are currently utilized in obstetrics surgery, mostly with surgical tape or Montgomery straps. However, there are currently no clinical trials comparing types of pannus retractors. Potential benefits from the Traxi retractor are decreased operating time, decreased need for additional operating room personnel, and increased ease of delivery of neonate. In addition, the Traxi is designed to stay on for 24 hours in order to elevate the pannus, this will decrease exposure to moisture and possibly other bacteria as the skin begins to heal.

    6. Conditions and Keywords

    Primary Disease or Condition Being Studied in the Trial, or the Focus of the Study
    Obese Patients Undergoing Cesarean Section

    7. Study Design

    Primary Purpose
    Supportive Care
    Study Phase
    Not Applicable
    Interventional Study Model
    Parallel Assignment
    Masking
    None (Open Label)
    Allocation
    Randomized
    Enrollment
    4 (Actual)

    8. Arms, Groups, and Interventions

    Arm Title
    Treatment
    Arm Type
    Active Comparator
    Arm Description
    Subjects will receive use of the Traxi pannus retractor when undergoing cesarean section
    Arm Title
    Standard
    Arm Type
    No Intervention
    Arm Description
    Patients will receive use of the standard of care option which is the montgomery straps
    Intervention Type
    Device
    Intervention Name(s)
    Traxi Pannus Retractor
    Intervention Description
    traxi® Panniculus Retractor is a retraction device used for retraction of the panniculus during surgical procedures. traxi retracts and holds the panniculus for the duration of the operation, freeing the surgeons hands and those of the staff to better care for the patient.
    Primary Outcome Measure Information:
    Title
    Wound Disruption Rates
    Description
    To determine if there is a difference in wound disruption rates, in obese patients who have Cesarean sections when the Traxi retractor is used during Cesarean sections, when compared to traditional pannus retractor techniques, montogmery straps.
    Time Frame
    24 hours from placement of device
    Secondary Outcome Measure Information:
    Title
    Duration of Surgery or Length of Time From Skin Incision to Delivery of the Infant
    Description
    To determine if there is a difference in duration of surgery or length of time from skin incision to delivery of the infant between the treatment group and the control/standard group.
    Time Frame
    At time of surgery
    Title
    Change in Hemoglobin
    Description
    To determine if there is a difference in change in hemoglobin between the control/standard group and the treatment group.
    Time Frame
    24 hours after surgery
    Title
    Estimated Blood Loss
    Description
    To determine if there is a difference in estimated blood loss between the treatment group and the control/standard group.
    Time Frame
    At time of surgery
    Title
    Postoperative Length of Stay
    Description
    To determine if there is a difference in postoperative length of stay between the treatment group and the control/standard group.
    Time Frame
    3-4 days
    Title
    Other Complication Rate
    Description
    To determine if there is a difference in other complication rates between the treatment group and the control/standard group.
    Time Frame
    6 weeks
    Title
    Need for Hospital Readmission or Emergency Room Visits
    Description
    To determine if there is a difference in need for hospital readmission or emergency room visits between the treatment group and the control/standard group.
    Time Frame
    6 weeks

    10. Eligibility

    Sex
    Female
    Minimum Age & Unit of Time
    14 Years
    Maximum Age & Unit of Time
    50 Years
    Accepts Healthy Volunteers
    No
    Eligibility Criteria
    Inclusion Criteria: Pregnant women with a BMI greater than or equal to 30 kg/m squared, aged 14-50 years old, undergoing non-emergent cesarean section for delivery and require pannus displacement for surgery. Physicians Inclusion would include any physician who routinely perform C-sections Exclusion Criteria: Patients undergoing emergency Cesarean-section Pre-existing concurrent infection including chorioamnionitis State of immunosuppression (ie. HIV, cancer) Long-term steroid use (>2 days) Patients with a BMI <30 kg/m2, or those with a BMI >/=30kg who do not require pannus retraction. If there is a rash in the area of retraction Adhesive/tape allergy. Physicians exclusion would include any physician who does not routinely perform C-sections.
    Overall Study Officials:
    First Name & Middle Initial & Last Name & Degree
    Jennifer Goldkamp, MD
    Organizational Affiliation
    St. Louis University
    Official's Role
    Principal Investigator

    12. IPD Sharing Statement

    Plan to Share IPD
    No

    Learn more about this trial

    The Effect of a Self-Retaining Pannus Retractor in Obese Patients Undergoing Cesarean Section

    We'll reach out to this number within 24 hrs